Breaking news

AI Expands Role In Consumer Healthcare And Drug Development

by THEFUTURE.TEAM

April 29, 2026

Artificial intelligence is increasingly used in consumer healthcare to manage personal data and support health-related decisions. Use cases range from administrative tasks, such as appointment scheduling and note-taking, to handling basic health queries. As these tools become more accessible, industry participants are encouraging broader use beyond routine functions.

AI As A Personal Health Advisor

The development of AI tools is extending into everyday health support. Alex Zhavoronkov, CEO of Insilico Medicine, said consumers can use AI systems to address routine health-related questions. Speaking at CNBC’s CONVERGE LIVE event in Singapore, he noted that some AI tools are capable of handling basic inquiries, allowing medical professionals to focus on more complex cases.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Major Tech Players Enter The Health Arena

At the same time, large technology companies are expanding into consumer health applications. OpenAI introduced ChatGPT Health, a platform that connects medical records and wellness applications to an AI interface. Similarly, Amazon launched HealthAI for users of One Medical, offering analysis of medical records, laboratory results, and current medications.

Balancing Innovation And Caution

As adoption increases, industry representatives are highlighting the need for oversight. Shreehas Tambe, CEO and Managing Director of Biocon, said that reliance on advanced systems without sufficient familiarity may introduce risks. He added that expert review remains necessary, particularly in areas such as drug development and clinical validation.

Revolutionizing Drug Discovery

Beyond consumer applications, AI is also reshaping pharmaceutical research. Development timelines for drug candidates can be reduced from more than four years to around 18 months. This shift is reflected in a $2.75 billion collaboration between Eli Lilly and Insilico Medicine, highlighting continued investment in AI-driven drug discovery.

The Future Forbes Realty Global Properties

A New Twitter-Inspired Social Network Is Taking Shape

by News Editor

August 27, 2026

A new social network called Twitter.now is entering the market, with a founding team that includes former Twitter trademark counsel Stephen Coates. The service is being developed by startup Operation Bluebird.

As Ars Technica reported, X sued the company last year and asked a Delaware judge to block the launch. Operation Bluebird argued in a petition that X had abandoned trademarks including “Twitter” and “Tweet.”

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Coates has said the project is not an attempt to recreate the original Twitter. In a LinkedIn post, he described the platform as a new public space focused on trust, transparency and user choice.

AI System To Rate Posts

Twitter.now is currently being tested, with early access priced at $20. Its main feature is VERA, an AI system designed to evaluate posts, verify claims and provide sources and context.

Posts receive a trust score, with users eventually able to set a minimum score to filter their feeds. The company says this approach will give people more control over what they see instead of leaving those decisions entirely to an algorithm.

Moderation Remains A Challenge

Scaling moderation will be one of the platform’s biggest tests. Social networks have repeatedly struggled with content moderation as their communities grow, and newer platforms such as Bluesky have faced similar criticism.

Operation Bluebird says VERA will form the basis of its moderation and verification system. A second version is already planned, with expanded tools that would let users set a specific trust threshold for the posts appearing in their feeds.

For now, Twitter.now remains in an early testing phase, combining the familiarity of the Twitter name with an AI-driven approach to evaluating online information.